DHA sbir phase II H2-0245
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH17C0212
- Awardee
-
X-Therma Inc. UEI MKP9GFAJNEY9
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $998,967
Award facts
- Opportunity
-
- HQ003416R1CDB Solicitation number
- Contract value 100% obligated
- $998,967.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 27 offers Negotiated Proposal / Quote
- Pricing
- Fixed Price Level of Effort
- Place of performance
- Vallejo, CA 94590, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $998,967 |
About this award
The Defense Health Agency awarded a $998,967 Small Business Innovation Research (SBIR) Phase II contract to X-Therma Inc., a minority-owned, woman-owned small business, on September 25, 2017. The contract, designated DHA SBIR PHASE II H2-0245, was awarded under the Total Small Business set-aside program with a fixed-price level-of-effort structure and a completion date of February 24, 2020. X-Therma Inc. performed the work at its facility in Vallejo, California, developing advanced biopreservation solutions to address critical challenges in organ transplantation and cell therapy.
X-Therma Inc. specializes in regenerative medicine and organ preservation technology, leveraging bioinspired next-generation cryoprotectants to extend the viability window of biological materials during storage and transport. Under this DHA-funded SBIR Phase II contract, the company advanced ex vivo preservation techniques for vascularized composite allografts at high subzero temperatures, building on previous Phase I research. This effort complements concurrent federal investments in the company's work, including substantial grants from the National Institutes of Health focused on porcine kidney preservation with the goal of extending the ischemia window to 120 hours, positioning X-Therma Inc. as a key innovator in improving outcomes for organ transplant patients.
Quick answers
Who was awarded contract W81XWH17C0212?
W81XWH17C0212 was awarded to X-Therma Inc. by Medical Command (Department of the Army) on September 21, 2017.
How much is contract W81XWH17C0212 worth?
The government has obligated $998,967 on W81XWH17C0212.
Which agency awarded contract W81XWH17C0212?
Medical Command (Department of the Army) awarded W81XWH17C0212, with funding from Defense Health Agency (Department of Defense).
Was contract W81XWH17C0212 competed?
The extent of competition for W81XWH17C0212 was full and open competition after exclusion of sources. The government received 27 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award